BRPI0815460A2 - kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos - Google Patents

kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos

Info

Publication number
BRPI0815460A2
BRPI0815460A2 BRPI0815460A BRPI0815460A BRPI0815460A2 BR PI0815460 A2 BRPI0815460 A2 BR PI0815460A2 BR PI0815460 A BRPI0815460 A BR PI0815460A BR PI0815460 A BRPI0815460 A BR PI0815460A BR PI0815460 A2 BRPI0815460 A2 BR PI0815460A2
Authority
BR
Brazil
Prior art keywords
diagnostic kit
mammalian subjects
predicting cancer
genes
proteins
Prior art date
Application number
BRPI0815460A
Other languages
English (en)
Inventor
Haibe-Kains Benjamin
Desmedt Christine
Sotiriou Christos
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Publication of BRPI0815460A2 publication Critical patent/BRPI0815460A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos". a presente invenção respeita a um conjunto de genes ou 5 proteínas consistindo em ou compreendendo pelo menos, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 10 possivelmente 100, 105, 110 genes ou proteínas ou o conjunto completo seleccionado a partir do quadro 10 e/ou do quadro 11 ou anticorpos (ou a porção hipervariável dos mesmos) dirigidos contra as proteínas codificadas por tais genes.
BRPI0815460A 2007-09-07 2008-09-05 kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos BRPI0815460A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97074307P 2007-09-07 2007-09-07
PCT/EP2008/061828 WO2009030770A2 (en) 2007-09-07 2008-09-05 Methods and tools for prognosis of cancer in er- patients

Publications (1)

Publication Number Publication Date
BRPI0815460A2 true BRPI0815460A2 (pt) 2019-02-26

Family

ID=40076838

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815460A BRPI0815460A2 (pt) 2007-09-07 2008-09-05 kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos

Country Status (7)

Country Link
US (1) US20100298160A1 (pt)
EP (1) EP2185728A2 (pt)
JP (1) JP2010537659A (pt)
AU (1) AU2008294687A1 (pt)
BR (1) BRPI0815460A2 (pt)
CA (1) CA2696947A1 (pt)
WO (1) WO2009030770A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
WO2010118782A1 (en) 2009-04-17 2010-10-21 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer
EP2270510A1 (en) * 2009-07-02 2011-01-05 EMBL (European Molecular Biology Laboratory) Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms
EP2649204A4 (en) * 2010-12-06 2014-05-21 Univ New Jersey Med A NEW METHOD FOR CANCER DIAGNOSIS AND PROSPECTIVENESS AND TO PREDICT THE RESPONSE TO THERAPY
US11047010B2 (en) * 2014-02-06 2021-06-29 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits thereof
JP7304030B2 (ja) * 2019-04-26 2023-07-06 国立大学法人 東京大学 がん治療の効果および予後の予測方法および治療手段の選択方法
DE102020203224A1 (de) 2020-03-12 2021-09-16 Heinrich-Heine-Universität Düsseldorf Inhibition von FKBP1A zur Therapie des Triple-negativen Mammakarzinoms
WO2021180840A1 (de) 2020-03-12 2021-09-16 Heinrich-Heine-Universität Düsseldorf Inhibition von fkbp1a zur therapie des triple-negativen mammakarzinoms
CN113025716A (zh) * 2021-03-02 2021-06-25 北京大学第一医院 一种用于人肿瘤分级的基因组合及其用途
US20260100247A1 (en) * 2022-09-30 2026-04-09 Foundation Medicine, Inc. Systems and methods for processing clinico-genomic data

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0323225D0 (en) * 2003-10-03 2003-11-05 Ncc Technology Ventures Pte Lt Materials and methods relating to breast cancer classification
EP1805676A1 (en) * 2004-09-22 2007-07-11 Tripath Imaging, Inc. Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
CN101356532B (zh) 2005-05-13 2012-08-01 布鲁塞尔自由大学 基于基因的算法型癌症预后
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
US20070218512A1 (en) * 2006-02-28 2007-09-20 Alex Strongin Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management

Also Published As

Publication number Publication date
EP2185728A2 (en) 2010-05-19
CA2696947A1 (en) 2009-03-12
WO2009030770A2 (en) 2009-03-12
US20100298160A1 (en) 2010-11-25
JP2010537659A (ja) 2010-12-09
AU2008294687A1 (en) 2009-03-12
WO2009030770A3 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
EP2001363A4 (en) SYSTEM, METHOD AND INSTRUMENTS FOR IMAGE-LEADED PROSTATE TREATMENT
DK1874818T3 (da) TGF-Beta 1-specifikke antistoffer
BRPI0506726B8 (pt) anticorpo monoclonal específico para m-csf e usos deste
WO2007109236A8 (en) Microrna fingerprints during human megakaryocytopoiesis
EA200802213A1 (ru) Способы лечения заболеваний крови
BR112015014751A2 (pt) anticorpos anti-tau humanos
MX2011006422A (es) Autoanticuerpos humanos anti-alfa-sinucleina.
PT1893196E (pt) Composto de diaril-hidantoína
DOP2009000269A (es) Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
MX338754B (es) Anticuerpos humanos contra el factor tisular.
MX2010005022A (es) Anticuerpos que unen celulas dendriticas y epiteliales 205 (dec-205) humanas.
BRPI0613382A8 (pt) anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
AU2006226733A8 (en) Antibodies against CD38 for treatment of multiple myeloma
NZ704295A (en) Compositions and methods for the treatment of infections and tumors
ATE455127T1 (de) Humane anti-humane cd3-bindungsmoleküle
EP1885399A4 (en) HUMANIZED ANTIBODIES TO CD40 AND METHOD FOR THEIR USE
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
MY145058A (en) Prlr-specific antibody and uses thereof
MX351889B (es) Composiciones y métodos anti-cxcr1.
MX2009005849A (es) Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas.
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
SG171598A1 (en) Blood group antigens of different types for diagnostic and therapeutic applications
FI20011664A7 (fi) Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A, 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]